Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.6%

77 terminated/withdrawn out of 393 trials

Success Rate

72.7%

-13.8% vs industry average

Late-Stage Pipeline

26%

104 trials in Phase 3/4

Results Transparency

2%

5 of 205 completed trials have results

Key Signals

55 recruiting5 with results74 terminated

Enrollment Performance

Analytics

N/A
166(51.7%)
Phase 3
75(23.4%)
Phase 2
40(12.5%)
Phase 4
29(9.0%)
Phase 1
11(3.4%)
321Total
N/A(166)
Phase 3(75)
Phase 2(40)
Phase 4(29)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (393)

Showing 20 of 393 trials
NCT01805271Phase 3Active Not Recruiting

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Role: collaborator

NCT06995287Phase 3Recruiting

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea

Role: collaborator

NCT05546606Not ApplicableTerminated

CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

Role: collaborator

NCT05114278Phase 4Terminated

Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)

Role: collaborator

NCT05774509Phase 1Active Not Recruiting

Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells

Role: collaborator

NCT04075981Phase 3Active Not Recruiting

Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)

Role: collaborator

NCT06748118Not ApplicableRecruiting

Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.

Role: collaborator

NCT05946564Phase 3Recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

Role: collaborator

NCT05524324Not ApplicableCompleted

Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT

Role: collaborator

NCT07010250Recruiting

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Role: collaborator

NCT06535945Phase 4Recruiting

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Role: collaborator

NCT04304651Not ApplicableActive Not Recruiting

Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism

Role: collaborator

NCT02388334Completed

Impact of Multiple Sclerosis From the Viewpoint of the Patients and Their Caregivers

Role: collaborator

NCT01556360Completed

Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study

Role: collaborator

NCT05329090Phase 3Completed

Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis

Role: collaborator

NCT05780762Not ApplicableRecruiting

Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies

Role: collaborator

NCT00221715Not ApplicableCompleted

Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein

Role: collaborator

NCT03357562Not ApplicableTerminated

MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

Role: collaborator

NCT04935684Phase 2Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Role: collaborator

NCT06560723Not ApplicableNot Yet Recruiting

Implementation of a Personalised Health Plan (PHP) on Patient Quality of Life Score at 2-year Follow-up

Role: collaborator